KRRO Korro Bio PE ratio, current and historical analysis
The current price-to-earnings ratio of KRRO can't be determined, as the TTM EPS of -$9.37 is negative. The last recorded PE ratio for Korro Bio was 0.24 in September 2024.
KRRO PE ratio history
The average historical PE ratio of Korro Bio for the last six years is 7.98. In the past six years, KRRO's PE ratio was at its highest in the Mar 2020 quarter at 31.25, when the stock price was $890.5 and the EPS was $28.5. The lowest value was in the Sep 2024 quarter, when it reached 0.24 with a price of $33.42 and an EPS of $140.73.
Korro Bio PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $38.07 | -$9.37 |
| 2023 | N/A | N/A | $47.93 | -$53.08 |
| 2022 | N/A | N/A | $192.5 | -$227.42 |
| 2021 | N/A | N/A | $256.5 | -$123.5 |
| 2020 | N/A | N/A | $1,763 | -$41 |
| 2019 | N/A | N/A | $876.5 | -$114.5 |
| 2018 | N/A | N/A | N/A | -$626.5 |
| 2017 | N/A | N/A | N/A | -$1,439.5 |
Korro Bio PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $38.07 | -$9.37 |
| Sep 2024 | 0.24 | -44.19% | $33.42 | $140.73 |
| Jun 2024 | 0.43 | -92.11% | $33.87 | $77.91 |
| Mar 2024 | 5.45 | N/A | $90 | $16.51 |
| Dec 2023 | N/A | N/A | $47.93 | -$53.08 |
| Sep 2023 | N/A | N/A | $18.5 | -$336.82 |
| Jun 2023 | N/A | N/A | $17.3 | -$299.47 |
| Mar 2023 | N/A | N/A | $25.15 | -$266.14 |
| Dec 2022 | N/A | N/A | $192.5 | -$227.42 |
| Sep 2022 | N/A | N/A | $89.5 | -$123.23 |
| Jun 2022 | N/A | N/A | $75 | -$132 |
| Mar 2022 | N/A | N/A | $106 | -$127.5 |
| Dec 2021 | N/A | N/A | $256.5 | -$123.5 |
| Sep 2021 | N/A | N/A | $353 | -$108 |
| Jun 2021 | N/A | N/A | $498 | -$79.5 |
KRRO average PE ratio chart
KRRO PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OLMA Olema Pharmaceuticals Inc | N/A | $222.08M |
| OMER Omeros Corp | N/A | $409.93M |
| ONVO Organovo Holdings Inc | N/A | $3.08M |
| ORIC Oric Pharmaceuticals Inc | N/A | $346.61M |
| ORMP Oramed Pharmaceuticals Inc | N/A | $85.79M |
| KRRO Korro Bio Inc. | N/A | $135.01M |
Frequently asked questions
What is Korro Bio's PE ratio?
The current price to earnings ratio of KRRO can't be calculated, as its EPS of -$9.37 is negative.
What is the 5-year average PE ratio for Korro Bio (KRRO)?
As an average over the last 5 years, KRRO stock has a PE ratio of 3.33.
What is the highest PE ratio for KRRO?
In the last six years, the Mar 2020 quarter recorded the highest quarterly PE ratio at 31.25.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.